Faculty Profiles - SUGAI Mika

写真a

SUGAI Mika

Organization

Academic Assembly Institute of Medicine and Dentistry Health Sciences Associate Professor
Faculty of Medicine School of Health Sciences Medical Technology Associate Professor

External link

Degree

博士（医学） ( 2009.9 新潟大学 )

Research Interests

細胞検査学

Research Areas

Life Science / Human pathology

Research History (researchmap)

Niigata University Faculty of Medicine School of Health Sciences Medical Technology Assistant Professor

2015.4

　 More details

researchmap

Research History

Niigata University Faculty of Medicine School of Health Sciences Medical Technology Associate Professor

2020.4
Niigata University Faculty of Medicine School of Health Sciences Medical Technology Assistant Professor

2015.4 - 2020.3

Education

Niigata University 医歯学総合研究科分子細胞医学専攻

2005.10 - 2009.9

　 More details

Country： Japan

researchmap

Professional Memberships

泌尿器細胞診(別府)カンファレンス

2016.2

　 More details

researchmap
Japanese Association of Medical Technologists

　 More details

researchmap
The Japanese Sciety of Pthology

　 More details

researchmap
The Japanese Society of Clinical Cytology

　 More details

researchmap

Committee Memberships

公益社団法人日本臨床細胞学会評議員

2019.4

　 More details

researchmap
公益社団法人日本臨床細胞学会細胞検査士認定試験問題作製委員

2013.4

　 More details

Committee type：Academic society

researchmap

Qualification acquired

Medical Technologist
細胞検査士
Cytotecnologist ( International Academy of Cytology)

Papers

Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. International journal

Hikaru Ozeki, Yoshifumi Shimada, Mae Nakano, Shuhei Kondo, Riuko Ohashi, Yamato Miwa, Daisuke Yamai, Akio Matsumoto, Kaoru Abe, Yosuke Tajima, Hiroshi Ichikawa, Jun Sakata, Yasumasa Takii, Mika Sugai, Takahiro Nagai, Yiwei Ling, Shujiro Okuda, Toshifumi Wakai

Human pathology 145 71 - 79 2024.3

　More details

Language：English Publishing type：Research paper (scientific journal)

Colorectal cancer (CRC) is a heterogeneous disease that develops through stepwise accumulation of genetic alterations and progresses via several distinct pathways. However, the tumorigenesis of CRCs with BRAF non-V600E mutations remains unclear. Here, we aimed to elucidate the tumorigenesis of CRCs with BRAF non-V600E mutations, focusing on differences in mucin phenotype and genetic alterations between CRCs with non-V600E and V600E mutations. We investigated 201 patients with CRC and performed panel testing of 415 genes to identify BRAF mutations. Patients were classified into five mucin phenotypes - large-intestinal, small-intestinal, gastric, mixed, and unclassified - using immunohistochemistry for CD10, MUC2, MUC5AC, and MUC6. BRAF mutations were identified in 24 of 201 patients' samples, of which 13 (6.5%) had a V600E mutation (V600E-mutant) and 11 (5.5%) had non-V600E mutations (non-V600E-mutant). MUC5AC expression was significantly associated with V600E mutations (P = 0.040), while CD10 expression was significantly associated with non-V600E mutations (P = 0.010). The small-intestinal mucin phenotype was significantly associated with non-V600E mutations (P = 0.031), while the mixed mucin phenotype was significantly associated with V600E mutations (P = 0.027). Regarding genetic alterations, focusing on the WNT signaling pathway, APC mutation was significantly associated with non-V600E mutations (P < 0.001), while RNF43 mutation was significantly associated with V600E mutations (P = 0.020). Considering the differences in mucin phenotype and genetic alterations, different modes of tumorigenesis are assumed for CRC with BRAF V600E mutation and non-V600E mutations. These findings are important in understanding the biology and treatment strategies for BRAF-mutant CRC.

DOI： 10.1016/j.humpath.2024.02.009

PubMed

researchmap
【胆道癌診療の最前線】胆道癌のゲノム医療

若井俊文, 島田能史, 奥田修二郎, 栗山洋子, 須貝美佳, 中野麻恵, 松本瑛生, 廣瀬雄己, 三浦宏平, 滝沢一泰, 市川寛, 坂田純

消化器外科 44 ( 2 ) 207 - 212 2021.2

　More details

Language：Japanese Publisher：(株)へるす出版

researchmap
Profiling of host genetic alterations and intra-tumor microbiomes in colorectal cancer. International journal

Shujiro Okuda, Yoshifumi Shimada, Yosuke Tajima, Kizuki Yuza, Yuki Hirose, Hiroshi Ichikawa, Masayuki Nagahashi, Jun Sakata, Yiwei Ling, Nobuaki Miura, Mika Sugai, Yu Watanabe, Shiho Takeuchi, Toshifumi Wakai

Computational and structural biotechnology journal 19 3330 - 3338 2021

　More details

Language：English Publishing type：Research paper (scientific journal)

Some bacteria are symbiotic in tumor tissues, and metabolites of several bacterial species have been found to cause DNA damage. However, to date, the association between bacteria and host genetic alterations in colorectal cancer (CRC) has not been fully investigated. We evaluated the association between the intra-tumor microbiome and host genetic alterations in 29 Japanese CRC patients. The tumor and non-tumor tissues were extracted from the patients, and 16S rRNA genes were sequenced for each sample. We identified enriched bacteria in tumor and non-tumor tissues. Some bacteria, such as Fusobacterium, which is already known to be enriched in CRC, were found to be enriched in tumor tissues. Interestingly, Bacteroides, which is also known to be enriched in CRC, was enriched in non-tumor tissues. Furthermore, it was shown that certain bacteria that often coexist within tumor tissue were enriched in the presence of a mutated gene or signal pathway with mutated genes in the host cells. Fusobacterium was associated with many mutated genes, as well as cell cycle-related pathways including mutated genes. In addition, the patients with a high abundance of Campylobacter were suggested to be associated with mutational signature 3 indicating failure of double-strand DNA break repairs. These results suggest that CRC development may be partly caused by DNA damage caused by substances released by bacterial infection. Taken together, the identification of distinct gut microbiome patterns and their host specific genetic alterations might facilitate targeted interventions, such as modulation of the microbiome in addition to anticancer agents or immunotherapy.

DOI： 10.1016/j.csbj.2021.05.049

PubMed

researchmap
Bepridil Inhibits Premature Ventricular Complexes Induced by Cardio-Sympathetic Nerve Stimulation in a Canine Experimental Model. Reviewed

Osamu Saitoh, Junya Watanabe, Ayari Sugai, Ayaka Oikawa, Mika Sugai, Masaomi Chinushi

International heart journal 61 ( 2 ) 338 - 346 2020.3

　More details

Language：English Publishing type：Research paper (scientific journal)

Sympathetic nerve activity has arrhythmogenic potential for ventricular arrhythmias associated with structural heart diseases. However, a sufficient amount of beta-blockers occasionally cannot be prescribed in some patients.An experimental study was performed to clarify the therapeutic effects of bepridil, a multiple ionic current inhibitor that does not affect beta-adrenergic receptors, for premature beats occurring during enhanced sympathetic nerve activity. Cardio-sympathetic nerve activity was augmented via stellate-ganglion (SG) stimulation in a canine model (n = 8), and the arrhythmogenic potential and anti-arrhythmic effects of bepridil (2 and 4 mg/kg intravenously) were assessed. For safe use, vagal-stimulation-induced slow HR and programmed electrical stimulation were applied to evaluate possible pro-arrhythmic effects of the drug. Heart rate variability (HRV) indexes were used to estimate cardio-autonomic nerve activity.Either side of the SG-stimulation increased BP and HR. Premature beats were induced in 10/16 SG-stimulations and it was more frequent in left (8/8) rather than right stimulation (2/8). Following 2 mg/kg drug administration, premature beats were still inducible in 8/16 stimulations (7/8 in left and 1/8 in right), but burden of the premature beats decreased from 87.1 ± 46.8 to 62.1 ± 42.6 beats. After 4 mg/kg administration, premature beats were inducible in one SG-stimulation. Proarrhythmic effects were not observed in all experiments. Steady-state HRV indexes and percent increases in SG-stimulation-induced BP-elevation and HR-acceleration were similar among the 3 periods (before, 2 and 4 mg/kg of the drug).Bepridil may be an option for ventricular arrhythmias developed during enhanced cardio-sympathetic nerve activity with minimal effect on autonomic nerve responses.

DOI： 10.1536/ihj.19-494

PubMed

researchmap
結節状、顆粒状、微細顆粒状、絨毛上、分葉状、脳回状 Reviewed

岩渕三哉, 須貝美佳

胃と腸 52 ( 5 ) 680 - 681 2017

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
Electrical stimulation-based evaluation for functional modification of renal autonomic nerve activities induced by catheter ablation Reviewed

Masaomi Chinushi, Katsuya Suzuki, Osamu Saitoh, Hiroshi Furushima, Kenichi Iijima, Daisuke Izumi, Akinori Sato, Mika Sugai, Mitsuya Iwafuchi

HEART RHYTHM 13 ( 8 ) 1707 - 1715 2016.8

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：ELSEVIER SCIENCE INC

BACKGROUND Catheter ablation of the renal artery can be performed without apparent angiographic stenosis. This suggests that renal nerve function can be attenuated with minor structural damage to the renal artery.
OBJECTIVE To clarify this hypothesis, we examined the relationship between electrical nerve stimulation (ENS)-induced blood pressure (BP) response and severity of histological injury of the renal artery using an acute canine model of renal artery ablation.
METHODS An irrigation catheter was inserted into the renal arteries of 8 dogs, and radiofrequency current was delivered at 15, 20, or 25 W. ENS was applied to each artery before and after ablation.
RESULTS Before ablation, ENS increased the BP and heart rate from 145 15/86 13 to 189 21/111 19 mm Hg and from 116 9 to 130 6 beats/min, respectively. Heart rate variability indices and serum catecholamine levels were elevated concomitantly. After ablation, the ENS -induced increase in BP and heart rate were markedly attenuated after 15 W ablation and those were nearly completely inhibited after 20 or 25 W ablation. An increase in heart rate variability indices and serum catecholamine levels became insignificant regardless of the applied energy. Renal artery angiograms revealed stenotic lesions only after 25 W ablation procedures. Histological studies showed mild to moderate injury of the arterial wall and autonomic nerves caused by 20 and 25 W ablation procedures, whereas only minor changes caused by 15 W ablation.
CONCLUSION Functional renal autonomic nerve ablation is potentially performable with the guidance of ENS.

DOI： 10.1016/j.hrthm.2016.04.021

Web of Science

PubMed

researchmap
血圧調整における左右腎交感神経興奮の役割（実験モデルの神経電気刺激と高周波アブレ―ション）. Reviewed

池主正臣, 鈴木克弥, 齋藤修, 大矢佳奈, 飯嶋賢一, 佐藤光希, 和泉大輔, 須貝美佳, 古嶋博司

心臓 48 ( 6 ) 608 - 616 2016

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

DOI： 10.11281/shinzo.48.608

researchmap
特集：よくわかる消化器神経内分泌腫瘍(NET/NEC) 株消化管 NEC/MANEC（大腸）の特徴. Reviewed

岩渕三哉, 須貝美佳, 林真也

消化器内視鏡 28 ( 11 ) 1812 - 1822 2016

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
尿路上皮腫瘍における異型度判定の可能性～尿中異型細胞のスコアリングの試み～

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 梅津哉

新潟県臨床細胞学会会報 ( 第29号 ) 1 - 8 2014.11

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
当院における超音波内視鏡下穿刺吸引法の実際 Reviewed

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 山本幹, 塩路和彦, 梅津哉

新潟医学会雑誌 129 ( 6 ) 317 - 325 2014.6

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
体腔液細胞診標本におけるHNF4α発現の検討～腫瘍細胞と非腫瘍細胞との鑑別及び原発巣推定の可能性～ Reviewed

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 内藤眞, 梅津哉

日本臨床細胞学会雑誌第53巻 ( 第3号 ) 176 - 181 2014.2

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

DOI： 10.5795/jjscc.53.176

researchmap
Comparison between Japanese Classification and 2010 WHO Classification of Endocrine Cell Tumors of the Digestive Tract Reviewed

第48巻 ( 第7号 ) 941 - 955 2013.6

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

DOI： 10.11477/mf.1403113852

researchmap
骨・軟部腫瘍の病理診断の問題点骨・軟部腫瘍に対する針生検の有用性

堀田哲夫, 梅津哉, 須貝美佳, 高橋加奈絵, 生越章, 川島寛之, 有泉高志, 遠藤直人

日本整形外科学会雑誌 84 ( 12 ) 1103 - 1107 2010.12

　More details

Language：Japanese Publisher：(公社)日本整形外科学会

表在性の軟部腫瘍や骨外性病変が触知できる骨腫瘍では触診しながら腫瘍または骨外病変を直接穿刺し、通常の骨腫瘍はX線透視下に穿刺を行った。深部の骨・軟部腫瘍に対してはCTガイド下に穿刺を行った。骨腫瘍および軟部腫瘍に対して行われた針生検983例のうち、最終的に切除材料または開放生検で確認ができた穿刺吸引細胞診(FNAC)359例(骨腫瘍90例、軟部腫瘍269例)、針組織生検(CNB)127例(骨腫瘍40例、軟部腫瘍87例)を対象とした。FNACでは、誤診はすべて偽陰性で3例に認めた。感度、特異度、偽陽性率、偽陰性率はそれぞれび94.3%、100%、0%、5%で、正診率は96.7%であった。CNBでは、臨床所見より判定が正しいものと判断された。誤診例はなかった。感度、特異度、偽陽性率、偽陰性率はそれぞれ100%、100%、0%、0%であり、正診率は100%であった。

researchmap
生検：骨・軟部腫瘍に対する穿刺吸引細胞診の有用性 (特集骨・軟部腫瘍-先端的研究と臨床の現況) Reviewed

堀田哲夫, 梅津哉, 須貝美佳, 生越章, 川島寛之, 遠藤直人

整形外科第61巻 ( 第8号 ) 783 - 786 2010.7

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors Reviewed

Takashi Ariizumi, Akira Ogose, Hiroyuki Kawashima, Tetsuo Hotta, Guidong Li, Yongjun Xu, Hajime Umezu, Mika Sugai, Naoto Endo

PATHOLOGY INTERNATIONAL 60 ( 3 ) 193 - 202 2010.3

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：WILEY-BLACKWELL PUBLISHING, INC

Podoplanin is known as a lymphatic marker because its expression is detected in lymphatic but not vascular endothelium. Podoplanin is also expressed in several normal tissues including osteocytes or osteoblasts. A systematic examination of the podoplanin expression was conducted in normal skeletal tissues and some bone tumor cell lines, and the diagnostic value determined in primary bone tumors. Podoplanin mRNA was expressed at a high level in bone marrow tissue and cartilage, and was upregulated with differentiation to osteoblasts in bone marrow cells. Strong podoplanin expression was seen in osteocytes, chondrocytes, and osteoblasts on immunohistochemistry. Podoplanin mRNA was expressed at a high level in several osteosarcoma and chondrosarcoma cell lines, whereas podoplanin was expressed at a low level in a Ewing's/primitive neuroectodermal tumor cell line. In the clinical samples, osteosarcomas (22/26) expressed podoplanin at various levels. In small cell osteosarcomas (2/2), podoplanin was expressed strongly, although the tissue samples included few diagnostic osteoids. Chondrosarcomas (10/10) expressed podoplanin strongly, and chondroblastomas (5/5) expressed podoplanin moderately, while podoplanin was absent or expressed at low levels in Ewing's sarcomas (0/5), chordomas (0/6) and giant cell tumors of bone (1/7). Therefore, podoplanin may be a sensitive immunohistochemical marker of osteogenic and chondrogenic bone tumors.

DOI： 10.1111/j.1440-1827.2009.02510.x

Web of Science

researchmap
Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors Reviewed

Mika Sugai, Hajime Umezu, Takashi Yamamoto, Shuying Jiang, Hiroko Iwanari, Toshiya Tanaka, Takao Hamakubo, Tatsuhiko Kodama, Makoto Naito

PATHOLOGY INTERNATIONAL 58 ( 11 ) 681 - 686 2008.11

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：WILEY-BLACKWELL

Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a member of the nuclear receptor superfamily and is expressed in several endodermal tissues. The aim of the present study was to examine the expression of HNF4 alpha on ovarian epithelial tumors with immunocytochemistry and immunohistochemistry using mAbs recognizing P1 and P2 promoter-driven HNF4 alpha. Ovarian mucinous adenoma, mucinous tumors of borderline malignancy, and mucinous adenocarcinoma had positive nuclear staining for HNF4 alpha (41/45, 91%). One-third (34%) of mucinous tumors had P1-positive staining and most had P1/P2-positive staining (93%). MUC2- and MUC5AC-positive staining was observed in 34% and 95% of mucinous tumors, respectively. The histological subtype of these mucinous tumors was not correlated with HNF4 alpha expression. On cytology it was found that cancer cells in the ascites from ovarian mucinous adenocarcinomas were HNF4 alpha positive, but tumor cells in ascites from other types of ovarian carcinomas were negative for HNF4 alpha. Thus, HNF4 alpha is demonstrated to be a useful marker for histological and cytological diagnosis of ovarian mucinous tumors.

DOI： 10.1111/j.1440-1827.2008.02293.x

Web of Science

researchmap
Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors Reviewed

Mika Sugai, Hajime Umezu, Takashi Yamamoto, Shuying Jiang, Hiroko Iwanari, Toshiya Tanaka, Takao Hamakubo, Tatsuhiko Kodama, Makoto Naito

PATHOLOGY INTERNATIONAL 58 ( 11 ) 681 - 686 2008.11

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：WILEY-BLACKWELL

Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a member of the nuclear receptor superfamily and is expressed in several endodermal tissues. The aim of the present study was to examine the expression of HNF4 alpha on ovarian epithelial tumors with immunocytochemistry and immunohistochemistry using mAbs recognizing P1 and P2 promoter-driven HNF4 alpha. Ovarian mucinous adenoma, mucinous tumors of borderline malignancy, and mucinous adenocarcinoma had positive nuclear staining for HNF4 alpha (41/45, 91%). One-third (34%) of mucinous tumors had P1-positive staining and most had P1/P2-positive staining (93%). MUC2- and MUC5AC-positive staining was observed in 34% and 95% of mucinous tumors, respectively. The histological subtype of these mucinous tumors was not correlated with HNF4 alpha expression. On cytology it was found that cancer cells in the ascites from ovarian mucinous adenocarcinomas were HNF4 alpha positive, but tumor cells in ascites from other types of ovarian carcinomas were negative for HNF4 alpha. Thus, HNF4 alpha is demonstrated to be a useful marker for histological and cytological diagnosis of ovarian mucinous tumors.

DOI： 10.1111/j.1440-1827.2008.02293.x

Web of Science

researchmap
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4 alpha in the pathogenesis of human cancer Reviewed

T Tanaka, S Jiang, H Hotta, K Takano, H Iwanari, K Sumi, K Daigo, R Ohashi, M Sugai, C Ikegame, H Umezu, Y Hirayama, Y Midorikawa, Y Hippo, A Watanabe, Y Uchiyama, G Hasegawa, PC Reid, H Aburatani, T Hamakubo, J Sakai, M Naito, T Kodama

JOURNAL OF PATHOLOGY 208 ( 5 ) 662 - 672 2006.4

　More details

Language：English Publishing type：Research paper (scientific journal) Publisher：WILEY

Hepatocyte nuclear factor-4 alpha (HNF4 alpha) exists in multiple isoforms that are generated by alternative promoter (PI and P2) usage and splicing. Here we establish monoclonal antibodies (mAbs) for detecting P1 and P2 promoter-driven HNF4 alpha, and evaluate their expression in normal adult human tissues and surgically resected carcinomas of different origins. Using immunohistochemical analysis, we demonstrate that, while P1 promoter-driven HNF4 alpha is expressed in hepatocytes, small intestine, colon, kidney and epididymis, P2 promoter-driven HNF4 alpha is expressed in bile duct, pancreas, stomach, small intestine, colon and epididymis. Altered expression patterns of PI and P2 promoter-driven HNF4 alpha were observed in gastric, hepatocellular and colorectal carcinomas. HNF4 alpha was expressed in lung metastases from renal cell, hepatocellular and colorectal carcinoma but was not observed in lung tumours. The P1 and P2 promoter-driven HNF4 alpha expression pattern of tumour metastases correlated with the primary site of origin. P1 promoter-driven HNF4 alpha was also found in intestinal metaplasia of the stomach. These data provide evidence for the tissue distribution of P1 and P2 promoter-driven HNF4 alpha at the protein level and suggest that HNF4 alpha may be a novel diagnostic marker for metastases of unknown primary. We propose that the dysregulation of alternative promoter usage of HNF4 alpha is associated with the pathogenesis of certain cancers. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

DOI： 10.1002/path.1928

Web of Science

researchmap
細胞診が有用であった悪性リンパ腫に伴う膝関節水腫 Reviewed

生越章, 堀田哲夫, 川島寛之, 須貝美佳, 梅津哉, 遠藤直人

整形外科第56巻 ( 5号 ) 580 - 581 2005.5

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
骨・軟部腫瘍に対する穿刺細胞診の有用性とその限界 Reviewed

堀田哲夫, 梅津哉, 須貝美佳, 生越章, 川島寛之, 遠藤直人

別冊整形外科 ( 第43号 ) 65 - 69 2003.12

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
Case report of carcinoma in situ of the fallopian tube found by mass screening for uterine cancer. Reviewed

IKARASHI Hirokazu, KODAMA Shoji, YOSHIYA Norio, TANAKA Kenichi, NAGAI Etsuko, EMURA Iwao, WATANABE Toru, SUGAI Mika

J. Jpn. Soc. Clin. Cytol. 第34巻 ( 第4号 ) 65 - 69 2003.12

　More details

Language：Japanese Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Clinical Cytology

We report a case of carcinoma in situ of the fallopian tube that was detected by atypical cells in a cervical smear obtained on mass screening for uterine cancer. Cervical cytology revealed large tumor cells which displayed overlapping clumps. The tumor cells had large oval nuclei with obvious anisonucleosis, high N/C ratios and fine granular chromatin, as well as prominent nucleoli. The specimen was thus diagnosed as class V, derived from adenocarcinoma. Furthermore, similar tumor cells were observed in the cytological specimens of an endometrial smear and intraperitoneal lavage. In the resected left fallopian tube, no macroscopically abnormal findings were noticed, but carcinoma in situ with increased stratification, micropapillary proliferation, nuclear atypia and abnormal mitotic figures without stromal invasion were detected histologically. The patient was treated with three courses of CAP chemotherapy after the primary operation and has been alive for 2 years and 10 months without signs of recurrence. Carcinoma of the fallopian tube is a rare disease and preoperative diagnosis of this disease has been considered to be difficult. The present case demonstrates that it is important to take this disease into consideration in cases in whom cervical or endometrial smears reveal adenocarcinoma cells even when few or no malignant tissues are observed histologically.

DOI： 10.5795/jjscc.34.666

CiNii Article

researchmap
細胞診で診断した pulmonary blastoma の一例

菅孝, 薄田浩幸, 江村巌, 白浜美佳, 渡辺徹

日本臨床細胞学会新潟支部会報 ( 第8号 ) 16 - 19 1994.9

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
穿刺細胞診検体の処理に関する検討～生理食塩水に浮遊させた細胞は何時間診断可能な状態で保持されるか？～

渡辺徹, 江村巌, 白浜美佳

日本臨床細胞学会新潟支部会報 ( 第8号 ) 5 - 11 1994.9

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
A case of spindle cell carcinoma in the uterine cervix. Reviewed

KAMISHIMA Tomoko, FUKUDA Takeaki, EMURA Iwao, WATANABE Tohru, SHIRAHAMA Mika, KODAMA Shohji, TANAKA Kenichi, NAITO Makoto

J. Jpn. Soc. Clin. Cytol. 第33巻 ( 第1号 ) 53 - 58 1994.1

　More details

Language：Japanese Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Clinical Cytology

A case of spindle cell carcinoma in the uterine cervix is presented.The tumor was encountered in a 52-year-old Japanese woman.Cytologic study of a vaginal smear showed several clusters of spindle-shaped malignant cells consisting of round and polygonal tumor cells containing round to slender nuclei with irregular margins, as well as one or two nucleoli, and focally aggregated chromatin.The cytoplasm was generally stained faintly light-green but a few showed darker staining.Although cytologic findings indicated non-epithelial tumor cell features, the cells also tended to form clusters.Although there was no evidence of squamous cell carcinoma in biopsy specimens from the uterine cervix and resected uterus, malignant tissue composed of spindle-shaped tumor cells was found.The tumor was limited to the uterine cervix and lacked epithelial elements. Immunohistochemical study revealed positive immunoreactions for keratin, epithelial membrane antigen, and vimentin. Ultrastructurally, some tumor cells possessed a small amount of tonofilament-like filaments and were connected to one another by desmosomes.These findings are consistent with spindle cell carcinoma, a variant of squamous cell carcinoma. We should keep in mind the possibility of spindle cell carcinoma in the uterine cervix.

DOI： 10.5795/jjscc.33.53

CiNii Article

researchmap
Cytological, radiological and pathological examination of bronchiloalveolar type adenocarcinoma with minimal fibrotic foci and invasive malignant tissue Reviewed

EMURA Iwao, SHIRAHAMA Mika, WATANABE Tooru, NAITOU Makoto

The Journal of the Japanese Society of Clinical Cytology 第33巻 ( 第1号 ) 19 - 26 1994.1

　More details

Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japanese Society of Clinical Cytology

DOI： 10.5795/jjscc.33.19

CiNii Article

CiNii Books

researchmap
非乳頭状移行上皮癌19例の細胞学的及び病理学的検討

江村巌, 白浜美佳, 渡辺徹

日本臨床細胞学会新潟支部会報 ( 第7号 ) 6 - 18 1993.9

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap
Diagnosis of keratotic squamous cell carcinoma of the uterine cervix using polarizing microscopy Reviewed

SHIRAHAMA Mika, WATANABE Tooru, EMURA Iwao, NAITO Makoto

The Journal of the Japanese Society of Clinical Cytology 第32巻 ( 第4号 ) 481 - 488 1993.7

　More details

Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japanese Society of Clinical Cytology

DOI： 10.5795/jjscc.32.481

CiNii Article

CiNii Books

researchmap
Diagnosis of keratotic squamous cell carcinoma of the lung using polarizing microscopy. Reviewed

EMURA Iwao, SHIRAHAMA Mika, WATANABE Tooru

The Journal of the Japanese Society of Clinical Cytology 第32巻 ( 第3号 ) 365 - 372 1993.5

　More details

Language：Japanese Publishing type：Research paper (scientific journal) Publisher：Japanese Society of Clinical Cytology

DOI： 10.5795/jjscc.32.365

CiNii Article

CiNii Books

researchmap
授乳期の乳腺上皮の形態変化を基礎とした乳腺穿刺細胞診のモルフォメトリーによる再検討

斉藤孝久, 木島美和子, 渡辺徹, 白浜美佳, 江村巌, 五十嵐俊彦

日本臨床細胞学会新潟支部会報 ( 第3号 ) 1 - 6 1992.9

　More details

Language：Japanese Publishing type：Research paper (scientific journal)

researchmap

▶ display all

Books

大腸疾患NOW2015[テーマ2]2.大腸の神経内分泌腫瘍の病理診断

岩渕三哉, 須貝美佳（ Role： Joint author）

日本メディカルセンター 2015.1

　More details

Language：Japanese Book type：Scholarly book

researchmap
臨床医のための胃がん病理アトラス学術誌『胃がんperspective』連載合本第8章その他の胃がん

岩渕三哉, 渡辺徹, 須貝美佳（ Role： Joint author）

メディカルレビュー社 2014.9

　More details

Language：Japanese Book type：Scholarly book

researchmap

MISC

Histological Characteristics of Histogenesis, Gastrointestinal Phenotype Expression, and Infiltrating lymphocytes of the Small Gastric Carcinoma with Lymphoid Stroma

Kosuge Yuuko, Iwafuchi Mitsuya, Sugai Mika, Hayashi Shinya

130 ( 10 ) 589 - 600 2016.10

　More details

Language：Japanese

CiNii Article

CiNii Books

researchmap

Other Link： http://hdl.handle.net/10191/47257
P-101 悪性顆粒細胞腫の2例(骨・軟部(3),グローバル時代の細胞診,第47回日本臨床細胞学会秋期大会)

須貝美佳, 高橋加奈絵, 梅津哉

日本臨床細胞学会雑誌 47 ( 2 ) 530 - 530 2008.9

　More details

Language：Japanese Publisher：特定非営利活動法人日本臨床細胞学会

CiNii Article

CiNii Books

researchmap
47 Hepatocyte nuclear factor 4α(HNF4α)の発現による卵巣腫瘍組織型推定の可能性(卵巣(3),一般演題,第46回日本臨床細胞学会秋期大会)

須貝美佳, 梅津哉, 高橋加奈絵, 山本尚, 内藤眞

日本臨床細胞学会雑誌 46 ( 2 ) 435 - 435 2007.9

　More details

Language：Japanese Publisher：特定非営利活動法人日本臨床細胞学会

CiNii Article

CiNii Books

researchmap
P-128 Hepatocyte nuclear factor 4α(HNF4α)による原発巣推定への可能性(骨軟部 1,一般演題・示説,第47回日本臨床細胞学会総会(春期大会))

須貝美佳, 梅津哉, 渡邊徹, 岩渕三哉, 内藤眞

日本臨床細胞学会雑誌 45 ( 1 ) 274 - 274 2006.3

　More details

Language：Japanese Publisher：特定非営利活動法人日本臨床細胞学会

CiNii Article

CiNii Books

researchmap
145 悪性が疑われた顆粒細胞腫の細胞像の検討(骨・軟部6)

須貝美佳, 梅津哉, 渡邊徹, 岩渕三哉, 江村巖

日本臨床細胞学会雑誌 43 ( 2 ) 475 - 475 2004.9

　More details

Language：Japanese Publisher：特定非営利活動法人日本臨床細胞学会

CiNii Article

CiNii Books

researchmap

Presentations

新報告様式と The Paris system の比較から考える尿細胞診報告様式統一の可能性

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 川口裕貴恵, 梅津哉

第62回日本臨床細胞学会春季大会（神奈川） 2021.6

　More details

Event date： 2021.6

Language：Japanese Presentation type：Symposium, workshop panel (nominated)

researchmap
体腔液中に出現するマクロファージの形態変化と病態に関連は見出せるか

須貝美佳, 岩渕三哉, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴恵, 梅津哉

第58回日本臨床細胞学会秋期大会（岡山） 2019.11

　More details

Event date： 2019.11

Language：Japanese Presentation type：Poster presentation

researchmap
気管支鏡下で採取した細胞診検体における肺組織マクロファージの表現型解析

川口裕貴恵, 岩渕三哉, 高橋加奈絵, 池亀央嗣, 横山千明, 梅津哉, 須貝美佳

第58回日本臨床細胞学会秋期大会（岡山） 2019.11

　More details

Event date： 2019.11

Language：Japanese Presentation type：Poster presentation

researchmap
子宮頸部細胞診標本における腺系異型細胞の解析～HNF4αの発現と細胞形態～

須貝美佳, 岩渕三哉, 高橋加奈絵, 池亀央嗣, 坂下千明, 川口裕貴恵, 梅津哉

第57回日本臨床細胞学会秋期大会（神奈川） 2018.11

　More details

Event date： 2018.11

Language：Japanese Presentation type：Poster presentation

researchmap
子宮頸部腺癌における Hepatocyte nuclear factor4α (HNF4α) の発現

須貝美佳, 梅津哉, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉, 本山悌一

第35回新潟県臨床細胞学会学術集会 2018.7

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
子宮頸部腺癌におけるHepatocyte nuclear factor4α(HNF4α)の発現

須貝美佳, 梅津哉, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉, 本山悌一

第59回日本臨床細胞学会総会 2018.6

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Adamantinoma の一例

須貝美佳, 梅津哉, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉

第56回日本臨床細胞学会秋季大会 2017.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
稀な骨腫瘍の一例

須貝美佳, 梅津哉, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉

第34回新潟県臨床細胞学会学術集会 2017.7

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
悪性顆粒細胞腫の一例

須貝美佳, 梅津哉, 大橋瑠子, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉

第55回日本臨床細胞学会秋季大会 2016.11

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
大腸がんにおけるRAS 遺伝子変異検索の検討

林真也, 池田友美, 橋詰香織, 八木美菜, 上原桂月, 建部勝彦, 高橋直子, 須貝美佳

第5回北日本医学検査学会 2016.10

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
HNF4αの発現による膵管内乳頭粘液性腫瘍 (IPMN)の悪性度分類の検討

山田健太郎, 大沼睦, 宮下真平, 宮ノ越裕理, 岩渕三哉, 須貝美佳

第5回北日本医学検査学会 2016.10

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
泌尿器細胞診新報告様式に則った異型細胞判定の再考

須貝美佳, 梅津哉, 大橋瑠子, 高橋加奈絵, 池亀央嗣, 横山千明, 川口裕貴江, 岩渕三哉

第33回日本臨床細胞学会新潟支部学術集会 2016.7

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
腎盂癌、尿管癌における尿中異型細胞の検討

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 大橋瑠子, 梅津哉, 岩渕三哉

第54回日本臨床細胞学会秋季大会 2015.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
尿路上皮腫瘍における尿中異型細胞スコアリングの試み

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 大橋瑠子, 梅津哉, 岩渕三哉

第54回日本臨床細胞学会秋季大会 2015.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
細胞診検体を用いたEGFR遺伝子変異検査における検体適否

林真也, 池田友美, 橋詰香織, 八木美菜, 上原桂月, 建部勝彦, 高橋直子, 岩渕三哉, 須貝美佳

第54回日本臨床細胞学会秋季大会 2015.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
胞巣状軟部肉腫の一例

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 大橋瑠子, 梅津哉

第29回関東臨床細胞学会 2015.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
大腸がんにおけるRAS 遺伝子変異検索の検討

林真也, 池田友美, 橋詰香織, 八木美菜, 上原桂月, 建部勝彦, 高橋直子, 須貝美佳

平成27年度（第4回）北日本支部医学検査学会 2015.10

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
上部尿路上皮癌と膀胱癌～尿中異型細胞の比較検討～

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 大橋瑠子, 梅津哉

第32回新潟県臨床細胞学会 2015.7

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
当院におけるEUS-FNA標本作製の実際～細胞検査士立ち会いの意義～

須貝美佳

第12回甲信越胆・膵内視鏡フォーラム 2014.11

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
骨髄細胞新診でパルボウイルス感染が疑われた一例

高橋加奈絵, 須貝美佳, 池亀央嗣, 坂下千明, 梅津哉

第31回新潟県臨床細胞学会学術集会 2014.6

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
EUS-FNA施行時の臨床医と細胞検査士のあり方

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 梅津哉

第63回日本医学検査学会 2014.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
膵腫瘤におけるEUS-FNA施行時の臨床医と細胞検査士のあり方

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 梅津

第52回日本臨床細胞学会秋期大会 2013.11

　More details

Language：Japanese Presentation type：Symposium, workshop panel (nominated)

researchmap
膵腫瘤におけるEUS-FNAの実際

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 梅津哉

第30回日本臨床細胞学会新潟支部学術集会 2013.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
尿路上皮系腫瘍における異型度判定の検討

須貝美佳, 高橋加奈絵, 池亀央嗣, 坂下千明, 梅津哉

第29回日本臨床細胞学会新潟支部学術集会 2012.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
集検にて発見された肺門部早期扁平上皮癌の一例

池亀央嗣, 須貝美佳, 高橋加奈絵, 坂下千明, 梅津哉, 島垣二佳子, 井上博子, 阿部美香

第29回日本臨床細胞学会新潟支部学術集会 2012.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
当院におけるEUS-FNA の実際

須貝美佳, 高橋加奈絵, 池亀央嗣, 横山明彩美, 梅津哉

第50回日本臨床細胞学会秋期大会 2011.10

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
当院におけるEUS-FNA、EBUS の実際

須貝美佳, 高橋加奈絵, 池亀央嗣, 横山明彩美, 梅津哉

第28回日本臨床細胞学会新潟支部学術集会 2011.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Intraductalpapillary neoplasm (IPMN)の細胞像

須貝美佳, 高橋加奈絵, 池亀央嗣, 梅津哉

第27回日本臨床細胞学会新潟支部学術集会 2010.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
子宮内膜細胞診で診断しえた卵巣 Serous papillary tumor の一例

高橋加奈絵, 須貝美佳, 池亀央嗣, 梅津哉

第27回日本臨床細胞学会新潟支部学術集会 2010.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
当院における膵液および膵管ブラッシング細胞診標本でのIPMN の検討

須貝美佳, 高橋加奈絵, 池亀央嗣, 内藤眞, 梅津哉

第51回日本臨床細胞学会総会 2010.5

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
原発巣推定におけるHepatocyte nuclear factor 4αの有用性～細胞診での検討を中心に～

須貝美佳, 梅津哉, 姜淑英, 内藤眞

平成22年度病理研究会 2010.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
当院における骨軟部腫瘍吸引細胞診と組織診との比較

須貝美佳, 高橋加奈絵, 池亀央嗣, 梅津哉

第26回日本臨床細胞学会新潟支部学術集会 2009.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
腎癌における Hepatocyte nuclear factor 4α(HNF4α)の発現

須貝美佳, 梅津哉, 姜淑英, 内藤眞

第98回病理学会総会示説 2009.5

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
腹水に腫瘍細胞を認めたSteroid cell tumor ,not other specified (NOS) of ovary の1例

高橋加奈絵, 須貝美佳, 池亀央嗣, 梅津哉

第26回日本臨床細胞学会新潟支部学術集会 2009.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
悪性顆粒細胞腫の2例～良悪性の鑑別の可能性～

須貝美佳, 高橋加奈絵, 梅津哉

第47回日本臨床細胞学会秋期大会 2008.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
卵巣腫瘍におけるHepatocyte nuclear factor 4α(HNF4α)の発現と組織型推定の可能性

須貝美佳, 梅津哉, 姜淑英, 山本尚, 内藤眞

第97回日本病理学会総会 2008.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
中皮腫の一例

高橋加奈絵, 須貝美佳, 梅津哉

第25回日本臨床細胞学会新潟支部学術集会 2008.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Hepatocyte nuclear factor 4α(HNF4α) を用いた卵巣腫瘍の組織型推定について

須貝美佳, 梅津哉, 姜淑英, 山本尚, 内藤眞

平成20年度病理研究会 2008.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Hepatocyte nuclear factor 4α(HNF4α) の発現による卵巣腫瘍組織型推定の可能性

須貝美佳, 梅津哉, 高橋加奈絵, 山本尚, 内藤眞

第46回日本臨床細胞学会秋期大会 2007.11

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
中皮細胞と腫瘍細胞の鑑別における Hepatocyte nuclear factor 4α(HNF4α) の有用性

須貝美佳, 梅津哉, 高橋加奈絵, 山本尚, 内藤眞

第21回日本臨床細胞学会関東連合会学術集会 2007.9

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Hepatocyte nuclear factor 4α(HNF4α)の発現~細胞診標本での原発巣推定の可能性~

須貝美佳, 梅津哉, 高橋加奈絵, 山本尚, 内藤眞

第24回日本臨床細胞学会新潟支部学術集会 2007.4

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Histological analyses of Granular cell tumor of soft tissue

須貝美佳, 梅津哉, 高橋加奈絵, 池亀央嗣, 児玉純子, 生越章, 堀田哲夫, 守田哲郎, 畠野宏史, 大塚寛

第39回日本整形外科学会骨・軟部腫瘍学術集会 2006.7

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Hepatocyte nuclearfactor4α(HNF4α) による原発巣推定への可能性

須貝美佳, 渡辺徹, 岩渕三哉, 梅津哉, 内藤眞

第47回日本臨床細胞学会総会 2006.6

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Spindle cell lipomaの一例

須貝美佳, 渡辺徹, 岩渕三哉, 梅津哉

第23回日本臨床細胞学会新潟支部学術集会 2006.5

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
腎癌における Hepatocyte nuclear factor 4α（HNF4α）の発現に関する免疫組織学的研究

須貝美佳, 梅津哉, 姜淑英, 内藤眞

第95回日本病理学会総会 2006.4

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Intra vascular lymphomatosis の2例～末梢血細胞診の有用性

須貝美佳, 渡辺徹, 江村巌

第37回日本臨床細胞学会秋期大会 1998.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
積極的肺部分切除を試みた肺腺癌44例の検討

江村巌, 渡辺徹, 須貝美佳

第37回日本臨床細胞学会秋期大会 1998.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Szanto等のHistologic Gradingと対比したAdenoid cystic carcinomaの細胞像

須貝美佳, 渡辺徹, 江村巌

第15回日本臨床細胞学会新潟支部学術集会 1998.3

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
Surface Syncytial Change(SSC)の細胞像

渡辺徹, 須貝美佳, 江村巌, 内藤眞

第36回日本臨床細胞学会秋期大会 1997.11

　More details

Language：Japanese Presentation type：Symposium, workshop panel (nominated)

researchmap
Primary serous papillary adenocarcinoma of the peritoney の一例

須貝美佳, 渡辺徹, 江村巌

第14回日本臨床細胞学会新潟支部学術集会 1997.3

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
診断に苦慮した子宮体部癌の検討

須貝美佳, 渡辺徹, 江村巌

第11回日本臨床細胞学会新潟支部学術集会 1994.6

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
類上皮肉腫の2例-潰瘍面の洗浄細胞診及び擦過面での検討

須貝美佳, 渡辺徹, 江村巌

第35回日本臨床細胞学会総会 1994.6

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Malignant progression の過程で観察される白血病細胞のDNA量の推移と形態変化および治療抵抗性白血病細胞の特徴

江村巌, 渡辺徹, 須貝美佳

第11回日本臨床細胞学会新潟支部学術集会 1994.6

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
低分化型子宮頸部腺癌の4例

福田剛明, 上島朋子, 内藤眞, 江村巌, 渡辺徹, 白浜美佳, 児玉省二

第32回日本臨床細胞学会秋期大会 1993.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
Well differentiated lipoma-like liposarcomaの2例

江村巌, 渡辺徹, 白浜美佳, 内藤眞

第32回日本臨床細胞学会秋期大会 1993.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
髄膜播種を来した子宮頸部腺癌の一例

上島朋子, 福田剛明, 内藤眞, 江村巌, 渡辺徹, 白浜美佳, 児玉省二

第32回日本臨床細胞学会秋期大会 1993.10

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
子宮頸部の spindle cell carcinoma の一例

福田剛明, 上島朋子, 江村巌, 渡辺徹, 白浜美佳, 児玉省二

第34回日本臨床細胞学会総会 1993.5

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
MDSにおける巨核球系細胞の形態異常

江村巌, 渡辺徹, 白浜美佳

第10回日本臨床細胞学会新潟支部学術集会 1993.3

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
子宮頸部擦過スメア―で発見された卵管采上皮内癌の一例

白浜美佳, 渡辺徹, 江村巌

第10回日本臨床細胞学会新潟支部学術集会 1993.3

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
偏光レンズによる肺扁平上皮癌の検討

江村巌, 渡辺徹, 白浜美佳

第33回日本臨床細胞学会総会 1992.6

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
偏光レンズによる子宮膣部扁平上皮癌の検討

白浜美佳, 渡辺徹, 江村巌

第33回日本臨床細胞学会総会 1992.6

　More details

Language：Japanese Presentation type：Poster presentation

researchmap
偏光レンズを使った角化型扁平上皮癌診断の試み②

渡辺徹, 白浜美佳, 江村巌

第9回日本臨床細胞学会新潟支部学術集会 1992.2

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap
偏光レンズを使った角化型扁平上皮癌診断の試み①

白浜美佳, 渡辺徹, 江村巌

第9回日本臨床細胞学会新潟支部学術集会 1992.2

　More details

Language：Japanese Presentation type：Oral presentation (general)

researchmap

▶ display all

Research Projects

BRAF変異陽性の大腸癌における分子病理学的特徴を加味した新しい分類法の確立

Grant number：23K08189

2023.4 - 2026.3

System name：科学研究費助成事業

Research category：基盤研究(C)

Awarding organization：日本学術振興会

中野麻恵, 島田能史, 田島陽介, 須貝美佳, 市川寛, 若井俊文, 阿部馨, 廣瀬雄己, 大関瑛

　 More details

Grant amount：\4680000 （ Direct Cost: \3600000 、 Indirect Cost：\1080000 ）

researchmap
不均一性の強い胃癌のHER2関連遺伝子異常を高精度に同定可能とする人工知能の開発

Grant number：22K07274

2022.4 - 2025.3

System name：科学研究費助成事業

Research category：基盤研究(C)

Awarding organization：日本学術振興会

臼井賢司, 宗岡悠介, 諸和樹, 島田能史, 梅津哉, 市川寛, 坂田純, 加納陽介, 須貝美佳, 奥田修二郎

　 More details

Grant amount：\4160000 （ Direct Cost: \3200000 、 Indirect Cost：\960000 ）

researchmap
食道癌術前化学療法の治療効果予測を目指したNQO1遺伝子多型の臨床的意義の解明

Grant number：22K08840

2022.4 - 2025.3

System name：科学研究費助成事業

Research category：基盤研究(C)

Awarding organization：日本学術振興会

石川卓, 宗岡悠介, 赤澤宏平, 廣瀬雄己, 若井俊文, 市川寛, 小杉伸一, 加納陽介, 須貝美佳

　 More details

Grant amount：\4160000 （ Direct Cost: \3200000 、 Indirect Cost：\960000 ）

researchmap
トリプルネガティブ乳癌における変異シグネチャー解析の臨床病理学的意義の解明

Grant number：22K08748

2022.4 - 2025.3

System name：科学研究費助成事業

Research category：基盤研究(C)

Awarding organization：日本学術振興会

土田純子, 諸和樹, 島田能史, 遠藤麻巳子, 永橋昌幸, 若井俊文, 凌一葦, 利川千絵, 須貝美佳

　 More details

Grant amount：\4160000 （ Direct Cost: \3200000 、 Indirect Cost：\960000 ）

researchmap
大腸癌の変異シグネチャーを予測するRadiogenomics解析法の確立

Grant number：22K08794

2022.4 - 2025.3

System name：科学研究費助成事業

Research category：基盤研究(C)

Awarding organization：日本学術振興会

松本瑛生, 宗岡悠介, 島田能史, 山崎元彦, 若井俊文, 凌一葦, 石川浩志, 長櫓宏規, 田島陽介, 須貝美佳, 山井大介

　 More details

Grant amount：\4030000 （ Direct Cost: \3100000 、 Indirect Cost：\930000 ）

researchmap

Teaching Experience (researchmap)

病態学III

2023.10
Institution name：三条看護・医療・歯科衛生専門学校

　More details

researchmap
病態学II

2021.10
Institution name：三条看護・医療・歯科衛生専門学校

　More details

researchmap
病態学I

2021.10
Institution name：三条看護・医療・歯科衛生専門学校

　More details

researchmap
Pathology I

2020.4

　More details

researchmap
Pathology II

2020.4

　More details

researchmap
臨床生理学概論

2018.12
Institution name：新潟医療技術専門学校

　More details

researchmap
臨床検査実習

2016.4

　More details

researchmap
医療英語（検査）

2016.4

　More details

researchmap
卒業研究

2016.4

　More details

researchmap
保健学特別研究（検査技術科学）

2016.4

　More details

researchmap
臨床検査管理概論

2015.4

　More details

Level：Undergraduate (specialized) Country：Japan

researchmap
病態病理検査学実習

2015.4

　More details

researchmap
Pathological practice I

2015.4

　More details

researchmap
Pathological practice II

2015.4

　More details

researchmap
細胞検査学実習

2015.4

　More details

researchmap
細胞診実習

2015.1

-

2021.3
Institution name：新潟医療技術専門学校

　More details

researchmap
臨床検査管理概論

　More details

researchmap
医学検査管理総論

　More details

researchmap
病理形態学実習Ⅰ

　More details

researchmap
医療英語（検査）

　More details

researchmap
卒業研究

　More details

researchmap

▶ display all

Teaching Experience

病態病理検査科学特講

2022
Institution name：新潟大学
生活習慣と健康

2021
Institution name：新潟大学
保健学総合

2021
Institution name：新潟大学
人体機能構造学I

2021
Institution name：新潟大学
病態病理検査科学特講演習

2021
Institution name：新潟大学
病理形態学Ⅰ

2020
Institution name：新潟大学
病理形態学Ⅱ

2020
Institution name：新潟大学
ケアの基本理念と実際

2020
Institution name：新潟大学
スタディスキルズ (検査)

2019
Institution name：新潟大学
保健学特別研究(検査技術科学)

2018
Institution name：新潟大学
医療安全管理学

2018
Institution name：新潟大学
病態病理検査学実習

2017
Institution name：新潟大学
病態病理検査学特論

2017
Institution name：新潟大学
病態病理検査科学特講演習

2017
Institution name：新潟大学
医学検査管理総論

2016
Institution name：新潟大学
臨床検査実習

2016
Institution name：新潟大学
医療英語(検査)

2016
Institution name：新潟大学
臨床検査管理概論

2015
Institution name：新潟大学
卒業研究

2015
Institution name：新潟大学
病理形態学実習Ⅰ

2015
Institution name：新潟大学
病理形態学実習Ⅱ

2015
Institution name：新潟大学

　More details

Level：Undergraduate (specialized)
細胞検査学実習

2015
Institution name：新潟大学

▶ display all